Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets

Transfusion and Apheresis Science

Volumn 30, Issue 1, 2004, Pages 29-39

  Wong, Kenneth ^a,b   Li, Xuebin ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITRITE; PADGEM PROTEIN; THROMBOCYTE CONCENTRATE;

ANALYSIS OF VARIANCE; ARTICLE; CELL PROTECTION; CELL SEPARATION; CELL SUSPENSION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; LABORATORY TEST; LEUKOCYTE; NITROSYLATION; PROTEIN ANALYSIS; PROTEIN SECRETION; STORAGE TEMPERATURE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION;

EID: 1642545687     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.07.001     Document Type: Article

References (42)

1. Klinger M.H. The storage lesion of platelets: ultrastructural and functional aspects. Ann. Hematol. 73:1996;103-112.
2. Seghatchian J., Krailadsiri P. The platelet storage lesion. Transfus. Med. Rev. 11:1997;130-144.
3. ′ adenosine monophosphate is necessary for preservation of platelet integrity during long-term storage at 22°C. Blood. 83:1994;1235-1243.
4. Mrowiec Z.R., Oleksowicz L., Zuckerman D., De Leon-Fernandez M., Khorshidi M., Dutcher J.P.et al. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage. Transfusion. 36:1996;5-10.
5. Rivera J., Lozano M.L., Corral J., Connor J., Gonzalez-Conejero R., Ferrer F.et al. Quality assessment of platelet concentrates supplemented with second-messenger effectors. Transfusion. 39:1999;135-143.
6. Wood E.M., Colton E., Yomtovian R.A., Currie L.M., Connor J., Anderson J.M. Prevention of monocyte adhesion and inflammatory cytokine production during blood platelet storage: an in vitro model with implications for transfusion practice. J. Biomed. Mater. Res. 51(2):2000;147-154.
7. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:1990;5193-5197.
8. Radomski M.W., Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv. Exp. Med. Biol. 344:1993;251-264.
9. Radomski M.W., Zakar T., Salas E. Nitric oxide in platelets. Meth. Enzymol. 269:1996;88-107.
10. Riddell D.R., Owen J.S. Nitric oxide and platelet aggregation. Vitam. Horm. 57:1999;25-48.
11. Buechler W.A., Ivanova K., Wolfram G., Drummer C., Heim J.M., Gerzer R. Soluble guanylyl cyclase and platelet function. Ann. NY Acad. Sci. 714:1994;151-157.
12. Moro M.A., Russel R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M.et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA. 93:1996;1480-1485.
13. McFarlane D.E., Mills D.C. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J. Cycl. Nucl. 7:1981;1-11.
14. Tsikas D., Ikic M., Tewes K.S., Raida M., Frolich J.C. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett. 442:1999;162-166.
15. Haslam R., Dickinson N., Jang E.K. Cyclic nucleotides and phosphodiesterases in platelets. Thromb. Haemost. 82:1999;412-423.
16. Yan B., Smith J.W. A redox site involved in integrin activation. J. Biol. Chem. 275:2000;39964-39972.
17. Pedigo M., Wun T., Paglieroni T. Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion. 339:1993;30-35.
18. Geiger T.L., Perrotta P.L., Davenport R., Baril L., Snyder E.L. Removal of anaphylatoxins C3a and C5a and chemokines interlukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion. 37:1997;1156-1162.
19. Krailadsiri P., Seghatchian J. Negatively charged leukocyte filter significantly enhances kallikrein and thrombin-like activities of platelet concentrates. Thromb. Res. 83:1996;469-474.
20. Devine D.V., Bradley A.J., Maurer E., Levin E., Chahal S., Serrano K.et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion. 39:1999;724-734.
21. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. Physiol. Soc. 271:1996;C1424-C1437.
22. O'Neill S., Dutta S., Triggle C. Computerized acquisition and analysis applied to chemiluminescence detection of nitric oxide in headspace gas. J. Pharmacol. Toxicol. Meth. 29:1993;217-221.
23. Trottier G., Triggle C., O'Neill S.K., Loutzenhiser R. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br. J. Pharmacol. 125:1998;563-569.
24. Park J., Kostka P. Fluorometric detection of biological S-nitrosothiols. Anal. Biochem. 249:1997;61-66.
25. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J.et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA. 89:1992;7674-7677.
26. Butler A.R., Rhodes P. Chemistry, analysis, and biological roles of S-nitrosothiols. Anal. Biochem. 249:1997;1-9.
27. Kelm M. Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta. 1411:1999;273-289.
28. Marley R., Feelisch M., Holt S., Moore K. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 32:2000;1-9.
29. Kostelijk E.H., Fijnheer R., Nieuwenhuis H.K., Gouwerok C.W., de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb. Haemost. 76:1996;1086-1089.
30. Bode A.P., Miller D.T., Newman S.L., Castellani W.J., Norris H.T. Plasmin activity and complement activation during storage of citrated platelet concentrates. J. Lab. Clin. Med. 113:1989;94-102.
31. Miletic V.D., Popovic O. Complement activation in stored platelet concentrates. Transfusion. 33:1993;150-154.
32. Gyongyossy-lssa M.I.C., McLeod E., Devine D.V. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets. J. Lab. Clin. Med. 123:1994;859-868.
33. Radomski M.W., Palmer R.M., Read N.G., Moncada S. Isolation and washing of human platelets with nitric oxide. Thromb. Res. 50:1988;537-546.
34. Lozano M., Estebanell E., Cid J., Diaz-Ricart M., Mazzara R., Ordinas A.et al. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion. 39:1999;951-959.
35. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelet and shear stress. Blood. 88:1996;1525-1541.
36. Polascik T., Godfrey P.P., Watson S.P. Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets. Biochem. J. 243:1987;815-819.
37. Keaney J.F. Jr., Simon D.I., Stamler J.S., Jaraki O., Scharfstein J., Vita J.A.et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91:1993;1582-1589.
38. Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 66:1990;1561-1575.
39. 2+ stores. Circ. Res. 84:1999;201-209.
40. Wang G.R., Zhu Y., Halushka P.V., Lincoln T.M., Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 95:1998;4888-4893.
41. Pigazzi A., Heydrick S., Folli F., Benoit S., Michelson A., Loscalzo J. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J. Biol. Chem. 274:1999;14368-14375.
42. Brune B., Hanstein K. Rapid reversibility of nitric oxide induced platelet inhibition. Thromb. Res. 90:1998;83-91.